Document is current
Any future updates will be listed below
-
Authors
Grover, Piyush https://orcid.org/0000-0001-5717-6507
Tang, Colin
Jacques, Angela
Kernutt, Elizabeth
Dass, Joshua
Dewar, Joanna
White, Rohen
Lim, Annette M. https://orcid.org/0000-0002-0777-2279
- License Information
-
More Information
Article History
Received: 16 April 2023
Accepted: 28 August 2025
First Online: 10 October 2025
Declarations
:
: The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Human Research Ethics Committee of the Sir Charles Gairdner Group (application number 12573). Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: PG reports consulting fees from Ipsen and Bristol-Myers Squibb and conference attendance support from Merck Sharp & Dohme, Ipsen, Bristol-Myers Squibb and Pierre Fabre. AML reports uncompensated consultancy for Pfizer, Lilly, Eisai and Merck Healthcare; institutional funding from Regeneron for an investigator sponsored trial, and institutional funding from Regeneron for translational research; receipt of conference registration support from Regeneron, and salary support from a Peter MacCallum Cancer Centre Discovery Partner Fellowship. Other authors have no relevant financial or non-financial interests to disclose.
